Cancer Drug Promising for Alzheimer ' s Disease Cancer Drug Promising for Alzheimer ' s Disease

In a small phase 2 trial, GM-CSF/sargramostim provided measurable disease-modifying and memory-enhancing benefits in patients with mild-to-moderate Alzheimer ' s disease.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Psychiatry News Source Type: news